Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis
The Regenerative Peptide Thymosin Beta-4 complements BPC-157 by targeting systemic repair
It is usually found in the brain and can easily cross the barrier between the blood and the brain
Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage
US$ 27.27
US$ 28.69
US$ 29.65
